Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
$6.71
+0.1700 ( +2.60% ) 77.4K
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Market Data
Open
$6.71
Previous close
$6.54
Volume
77.4K
Market cap
$183.88M
Day range
$6.51 - $6.81
52 week range
$5.66 - $11.92
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Mar 21, 2024 |
8-k/a | 8K-related | 16 | Mar 06, 2024 |
8-k | 8K-related | 16 | Feb 29, 2024 |
8-k | 8K-related | 16 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Dec 29, 2023 |
4 | Insider transactions | 1 | Dec 28, 2023 |
8-k | 8K-related | 18 | Dec 06, 2023 |
4 | Insider transactions | 1 | Nov 20, 2023 |
4 | Insider transactions | 1 | Nov 16, 2023 |